pegfpc1 fusion mammalian protein expression vector Search Results


95
Addgene inc vector pegfp c1
Vector Pegfp C1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/pEGFP(C1)-RepoMan+(Plasmid+%2344212)/pmc11849630-199-17-21
Average 95 stars, based on 1 article reviews
vector pegfp c1 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

93
Addgene inc pegfp c1 nphp5
Pegfp C1 Nphp5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/pEGFP(C1)-NIPP1+(Plasmid+%2344221)/pmc11104825-120-11-18
Average 93 stars, based on 1 article reviews
pegfp c1 nphp5 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Promega the mammalian expression vector pegfp-c1
The Mammalian Expression Vector Pegfp C1, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/gfp+expressing+plasmid+pegfp+c1/pm19054385-113-37-41
Average 90 stars, based on 1 article reviews
the mammalian expression vector pegfp-c1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson pegfp-c1
Pegfp C1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/pegfp+c1/pmc03162436-242-28-29
Average 90 stars, based on 1 article reviews
pegfp-c1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Addgene inc gfp
(A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected <t>with</t> <t>GFP-C1</t> or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).
Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/pEGFP-C1-ER+alpha+(Plasmid+%2328230)/pmc08051802-83-9-13
Average 93 stars, based on 1 article reviews
gfp - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Addgene inc pmcherry c1
(A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected <t>with</t> <t>GFP-C1</t> or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).
Pmcherry C1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/pmCherry-C1+mCherry-NLS+(Plasmid+%2358476)/pmc11849630-199-20-21
Average 94 stars, based on 1 article reviews
pmcherry c1 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
ATeam Scientific pegfpc1
(A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected <t>with</t> <t>GFP-C1</t> or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).
Pegfpc1, supplied by ATeam Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/pegfpc1/pmc05486644-24-38-42
Average 90 stars, based on 1 article reviews
pegfpc1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

95
Cytiva Europe pgex 4t 2
(A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected <t>with</t> <t>GFP-C1</t> or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).
Pgex 4t 2, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/PGEX-4T-2/pmc05473537-40-8-9
Average 95 stars, based on 1 article reviews
pgex 4t 2 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

90
Promega plasmid pfn21ahyg-egfp
(A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected <t>with</t> <t>GFP-C1</t> or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).
Plasmid Pfn21ahyg Egfp, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/plasmid+pfn21ahyg+egfp/10__1074_slash_jbc__m111__291625-51-0-28
Average 90 stars, based on 1 article reviews
plasmid pfn21ahyg-egfp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

bst  (OriGene)
96
OriGene bst
(A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected <t>with</t> <t>GFP-C1</t> or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).
Bst, supplied by OriGene, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pegfpc1+fusion+mammalian+protein+expression+vector/pCMV6-XL5+Mammalian+Expression+Vector/pm20529266-216-1-8
Average 96 stars, based on 1 article reviews
bst - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


(A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected with GFP-C1 or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).

Journal: PLoS ONE

Article Title: CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells

doi: 10.1371/journal.pone.0246264

Figure Lengend Snippet: (A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected with GFP-C1 or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).

Article Snippet: pGFP-C1-ERα (GFP-ERα), a mammalian expression of ERα fused to GFP, was purchased from Addgene (#28230; Watertown, MA, USA).

Techniques: Western Blot, Expressing, Transfection, Plasmid Preparation, MTT Assay

Immunoblots for PI3K/AKT/mTOR/S6K and ERK signaling-associated proteins in (A-D) MCF-7, ( E-H) MDA-MB-231, and (I-K) GFP-ERα-overexpressed MDA-MB-231 cells. Western blotting analysis from the breast cells transfected with control siRNA ( NC ) or CSNK1G2 siRNA ( CSNK1G2 ) were performed after treatment with vehicle or 1 μM TAM for 24 h. Protein expression levels based on individual bands of phosphor were compared to expression levels of α-tubulin and/or pan (total) protein. Each value under the blots indicates relative protein expression levels determined by densitometric analysis. Data are presented as mean (SD); n = 4.

Journal: PLoS ONE

Article Title: CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells

doi: 10.1371/journal.pone.0246264

Figure Lengend Snippet: Immunoblots for PI3K/AKT/mTOR/S6K and ERK signaling-associated proteins in (A-D) MCF-7, ( E-H) MDA-MB-231, and (I-K) GFP-ERα-overexpressed MDA-MB-231 cells. Western blotting analysis from the breast cells transfected with control siRNA ( NC ) or CSNK1G2 siRNA ( CSNK1G2 ) were performed after treatment with vehicle or 1 μM TAM for 24 h. Protein expression levels based on individual bands of phosphor were compared to expression levels of α-tubulin and/or pan (total) protein. Each value under the blots indicates relative protein expression levels determined by densitometric analysis. Data are presented as mean (SD); n = 4.

Article Snippet: pGFP-C1-ERα (GFP-ERα), a mammalian expression of ERα fused to GFP, was purchased from Addgene (#28230; Watertown, MA, USA).

Techniques: Western Blot, Transfection, Control, Expressing

(A) Cytotoxicity assay of either GFP-C1 or GFP-ERα-transfected ER - breast cancer cells. Bar denote relative percentage of % survival of transfected MDA-MB-231 cells after treatment with vehicle, 1 μM TAM, 2 μM D4476, and 1 μM TAM plus 2 μM D4476 for 24h. Cellular toxicity was measured using the MTT assay (mean (SD), n = 5; * P < 0.05, ** P < 0.01 vs . each represented counterpart). (B) Western blotting analysis from GFP-ERα-transfected ER - breast cells treated with vehicle or 2 μM D4476 together with 1 μM TAM for 24 h were performed. Immunoblots for PI3K/AKT/mTOR/S6K signaling-associated proteins in ER - MDA-MB-231 cells. Protein expression levels based on individual bands of phosphor were compared to expression levels of α-tubulin and/or pan (total) protein. Each value under the blots indicates relative protein expression levels determined by densitometric analysis (mean ± SEM, n = 4).

Journal: PLoS ONE

Article Title: CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells

doi: 10.1371/journal.pone.0246264

Figure Lengend Snippet: (A) Cytotoxicity assay of either GFP-C1 or GFP-ERα-transfected ER - breast cancer cells. Bar denote relative percentage of % survival of transfected MDA-MB-231 cells after treatment with vehicle, 1 μM TAM, 2 μM D4476, and 1 μM TAM plus 2 μM D4476 for 24h. Cellular toxicity was measured using the MTT assay (mean (SD), n = 5; * P < 0.05, ** P < 0.01 vs . each represented counterpart). (B) Western blotting analysis from GFP-ERα-transfected ER - breast cells treated with vehicle or 2 μM D4476 together with 1 μM TAM for 24 h were performed. Immunoblots for PI3K/AKT/mTOR/S6K signaling-associated proteins in ER - MDA-MB-231 cells. Protein expression levels based on individual bands of phosphor were compared to expression levels of α-tubulin and/or pan (total) protein. Each value under the blots indicates relative protein expression levels determined by densitometric analysis (mean ± SEM, n = 4).

Article Snippet: pGFP-C1-ERα (GFP-ERα), a mammalian expression of ERα fused to GFP, was purchased from Addgene (#28230; Watertown, MA, USA).

Techniques: Cytotoxicity Assay, Transfection, MTT Assay, Western Blot, Expressing